According to IMARC Group's latest report, titled "Next-Generation Sequencing (NGS) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027", the global next-generation sequencing (NGS) market reached a value of US$ 13.82 Billion in 2021. Looking forward, IMARC ...
“We are honored to be named the Most Innovative Next-Gen Sequencing Company”, Duncan YU, President of MGI, stated, “Next-generation sequencing (NGS) has transformed genomics research and its application in healthcare across various fields, driving the utilization of genomics for the betterment ...
Introduced for commercial use in 2005, this method was initially called “massively-parallel sequencing”, because it enabled the sequencing of many DNA strands at the same time, instead of one at a time as with...
Luckily, next-generation sequencing, also known as massively parallel sequencing, has evolved to the point of consistently providing high-resolution, high-accuracy results. EDITORIAL CONTENT 2 More 9/11 Victims ID'ed Days Before 20th Anniversary As part of the largest and most complex forensic ...
Next-generation sequencing (NGS) has taken center stage in the scientific world. It is a powerful tool for discovery, validation and verification in a plentitude of applications. This ranges from genetic disease discovery in the human genome, to elucidating the transmission of pathogens in our ...
Explore our next-generation sequencing products, get in touch for a quotation or register and order directly.
“The G4 brings together innovations in chemistry, molecular biology and engineering to deliver precision, speed and versatility,” says Eli Glezer, PhD, chief scientific officer of Singular Genomics. “We believe this new platform will expand and accelerate the use of DN...
The global next generation sequencing market is majorly dominated by the U.S. players. Companies belonging to the U.S. such as Illumina, Inc. and Thermo Fisher Scientific have been reported to contribute more than 60% of the market value in 2016. The key players which have significant ...
Globally, companies in the next generation sequencing market are Roche, Qiagen, Agilent, Bio-Rad Laboratories, BGI, Thermo Fisher Scientific, Illumina, and Genapsys. These organizations are focusing on new product launches, partnerships, and mergers to boost their market position. ...
While the sequencing companies compete to increase throughput, they have also launched systems with lower capacity. The reason for this trend is that the high capacity of the original systems is not always required, and the current multiplexing possibilities do not match their throughput, which resul...